| Issue Type | XXXX |
|---|---|
| Country | United Kingdom |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2046-06-15 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 0.00 |
| Coupon | 5.25 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 1000.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Mylan N.V. corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million USD and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Mylan N.V., founded in 1961 and headquartered in Canonsburg, Pennsylvania, is a global pharmaceutical company dedicated to providing access to high-quality medicines. Mylan specializes in the development, manufacturing, and distribution of generic and specialty pharmaceuticals, with a significant portfolio that includes over 1,400 different products spanning various therapeutic areas.